Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Shares Issued
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Shares Outstanding for 7 consecutive years, with $25.5 million as the latest value for Q1 2025.

  • Quarterly Shares Outstanding rose 837.55% to $25.5 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $25.5 million through Mar 2025, up 837.55% year-over-year, with the annual reading at $10.1 million for FY2024, 503.42% up from the prior year.
  • Shares Outstanding hit $25.5 million in Q1 2025 for Benitec Biopharma, up from $23.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $25.5 million in Q1 2025 to a low of $480688.0 in Q2 2021.
  • Historically, Shares Outstanding has averaged $7.2 million across 5 years, with a median of $2.7 million in 2024.
  • Biggest five-year swings in Shares Outstanding: crashed 81.42% in 2022 and later skyrocketed 837.55% in 2025.
  • Year by year, Shares Outstanding stood at $8.2 million in 2021, then plummeted by 79.86% to $1.6 million in 2022, then surged by 57.5% to $2.6 million in 2023, then soared by 804.61% to $23.5 million in 2024, then rose by 8.93% to $25.5 million in 2025.
  • Business Quant data shows Shares Outstanding for BNTC at $25.5 million in Q1 2025, $23.5 million in Q4 2024, and $17.9 million in Q3 2024.